People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Collidion Inc. | — | Pharmaceuticals | Series A | $14.5M | $8.5M | 2016 |
Elliot Maza at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elliot Maza on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hojabr Alimi | 1 | 3 |
| Sameer Harish | 1 | 3 |
| Gregg Alton | 1 | 2 |
| William H. Watson | 1 | 2 |
| Mark Fenlon | 1 | 1 |
| Ettore M. Carino | 1 | 1 |
| Gregory H. French | 1 | 1 |
| Jeffrey H. Castillo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.